Kiniksa Pharmaceuticals International Ownership | Who Owns Kiniksa Pharmaceuticals International?


OverviewForecastRevenueFinancialsChartTranscripts

Kiniksa Pharmaceuticals International Ownership Summary


Kiniksa Pharmaceuticals International is owned by 61.45% institutional investors, 3.49% insiders, and 35.06% retail investors. Fmr is the largest institutional shareholder, holding 9.11% of KNSA shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.72% of its assets in Kiniksa Pharmaceuticals International shares.

KNSA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockKiniksa Pharmaceuticals International61.45%3.49%35.06%
SectorHealthcare Stocks 50.44%12.38%37.18%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr6.97M9.11%$445.82M
Rubric capital management lp4.00M5.23%$255.79M
Vanguard group3.11M4.23%$128.41M
Baker bros. advisors lp2.83M3.70%$181.28M
Blackrock funding, inc. /de2.74M3.58%$175.20M
Tang capital management2.26M2.95%$144.52M
Vanguard capital management1.36M1.78%$87.03M
Morgan stanley1.01M1.32%$64.66M
Arrowstreet capital, limited partnership957.51K1.25%$61.23M
Dimensional fund advisors lp874.79K1.14%$55.94M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tang capital management2.26M6.56%$144.52M
Lion point capital, lp23.40K5.16%$908.62K
Rubric capital management lp4.00M2.35%$255.79M
Stempoint capital lp209.23K2.30%$13.38M
Essex investment management241.38K2.02%$15.44M
Rice hall james & associates624.93K1.95%$39.96M
Penn capital management company368.11K1.49%$23.57M
Lisanti capital growth87.31K1.23%$5.58M
Baker bros. advisors lp2.83M0.91%$181.28M
Globeflex capital l p93.40K0.76%$5.97M

Top Buyers

HolderShares% AssetsChange
Blackrock funding, inc. /de2.74M0.00%2.25M
Invesco772.81K0.00%745.15K
State street704.19K0.00%627.56K
Geode capital management604.18K0.00%559.86K
Janus henderson group481.02K0.01%327.60K

Top Sellers

HolderShares% AssetsChange
Blackrock---4.19M
Hhlr advisors---1.58M
Fairmount funds management---1.32M
Nuveen asset management---831.10K
Acadian asset management679.08K0.05%-657.23K

New Positions

HolderShares% AssetsChangeValue
Stempoint capital lp209.23K2.30%209.23K$13.38M
Sixth street partners management company101.58K0.00%101.58K$6.50M
Segall bryant & hamill71.90K0.05%71.90K$4.60M
Renaissance68.08K0.01%68.08K$4.35M
Adage capital partners gp59.00K0.00%59.00K$2.29M

Sold Out

HolderChange
Twin peaks wealth advisors-1.00
Clearstead advisors-2.00
Advisory services network-8.00
Caitong asset management-15.00
Optima capital-18.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202627417.09%47,017,9873.55%611.64%15835.04%82-5.75%
Mar 31, 2026144-36.28%15,964,705-62.83%210.63%77-35.29%47-32.86%
Dec 31, 202561-70.67%7,296,166-82.12%90.32%27-74.53%19-72.86%
Sep 30, 202571-62.83%6,310,956-84.11%80.29%41-63.06%20-67.74%
Jun 30, 20251906.74%39,714,3312.46%541.90%11015.79%6212.73%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.25M1.72%-
Vanguard Total Stock Mkt Idx Inv1.32M1.71%21.86K
Vanguard Morn Total Stk Mkt Idx Investor1.32M1.69%21.86K
iShares Russell 2000 ETF1.07M1.37%-19.01K
Pictet Biotech965.39K1.36%965.39K
Vanguard Small Cap Index955.92K1.24%5.23K
Fidelity Select Health Care905.57K1.16%60.66K
Strategic Advisers Fidelity US TtlStk649.25K0.83%48.20K
Fidelity Select Biotechnology637.60K0.82%-
Vanguard Institutional Extnd Mkt Idx Tr567.21K0.80%795.00

Recent Insider Transactions


DateNameRoleActivityValue
Jul 29, 2026Cole G Bradley-Sell$299.09K
May 01, 2026Paolini John F. CHIEF MEDICAL OFFICERSell$2.00M
May 01, 2026Paolini John F. CHIEF MEDICAL OFFICERSell$1.14M
May 01, 2026Patel Sanj K CHAIRMAN & CEOSell$2.62M
Apr 28, 2026Patel Sanj K CHAIRMAN & CEOSell$12.67M

Insider Transactions Trends


DateBuySell
2026 Q3-1
2026 Q2-14
2026 Q1-12
2025 Q4-17
2025 Q3-19

KNSA Ownership FAQ


Who owns the most shares of Kiniksa Pharmaceuticals International?

Kiniksa Pharmaceuticals International’s largest shareholders are Fmr (6.97M shares, 9.11%), Rubric capital management lp (4M shares, 5.23%), and Vanguard group (3.11M shares, 4.23%). Together, they hold 18.57% of Kiniksa Pharmaceuticals International’s total shares outstanding.

Does Blackrock own Kiniksa Pharmaceuticals International?

BlackRock is not among the top 10 institutional shareholders of Kiniksa Pharmaceuticals International.

Who is Kiniksa Pharmaceuticals International’s biggest shareholder by percentage of total assets invested?

Tang capital management is Kiniksa Pharmaceuticals International’s biggest shareholder by percentage of total assets invested, with 6.56% of its assets in 2.26M Kiniksa Pharmaceuticals International shares, valued at 144.52M$.

Who is the top mutual fund holder of Kiniksa Pharmaceuticals International shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Kiniksa Pharmaceuticals International shares, with 1.72% of its total shares outstanding invested in 1.25M Kiniksa Pharmaceuticals International shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools